Blaney Joseph

USPTO Trademark & Patent Filings

Trademark applications and grants for Blaney Joseph. Blaney Joseph has 2 trademark applications. The latest application filed is for "TEXAS STRONG"

Company Profile

Blaney, Joseph
joseph blaney
Blaney; Joseph - Gettysburg PA
Blaney; Joseph - Frederick MD

Trademarks Patents

Patent Applications

Patent Application	Date
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1,2,3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1,2,3, AND 4 20200392469 - 17/009448 Whitehead; Stephen S. ; et al.	2020-12-17
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1, 2, 3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4 20180010099 - 15/710672 Whitehead; Stephen S. ; et al.	2018-01-11
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1, 2, 3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4 20130011433 - 13/305639 Whitehead; Stephen S. ; et al.	2013-01-10
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3' -UTR OF DENGUE TYPES 1, 2, 3, AND 4 OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4 20090258036 - 12/398043 Whitehead; Stephen S. ; et al.	2009-10-15
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 20070009552 - 10/970640 Whitehead; Stephen S. ; et al.	2007-01-11
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 10,837,003 - 15/710,672 Whitehead , et al. November 17, 2	2020-11-17
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 9,783,787 - 13/305,639 Whitehead , et al. October 10, 2	2017-10-10
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 9,783,787 - 13/305,639 Whitehead , et al. October 10, 2	2017-10-10
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 8,075,903 - 12/398,043 Whitehead , et al. December 13, 2	2011-12-13
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 7,517,531 - 10/970,640 Whitehead , et al. April 14, 2	2009-04-14

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"TEXAS STRONG" 86193057	TEXAS STRONG 2014-02-13
"BROADWAY JOE" 78705184	BROADWAY JOE 2005-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.